Search Orphan Drug Designations and Approvals
-
Generic Name: | eculizumab |
---|---|
Date Designated: | 01/10/2014 |
Orphan Designation: | Prevention of delayed graft function after renal transplantation |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Alexion Pharmaceuticals, Inc. 121 Seaport Boulevard Boston, Massachusetts 02210 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-